Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Schick Technologies

This article was originally published in The Gray Sheet

Executive Summary

Nasdaq delisting notice is received by the maker of digital radiographic imaging systems for the dental and medical markets based on its inability to timely file its form 10-K annual report for the fiscal year ended March 31 and other factors. A review of the decision will be requested. PricewaterhouseCoopers resigned Aug. 25 as the firm's independent auditor and Schick subsequently retained Grant Thornton LLP as a replacement. At the time of PWC's resignation, the company accounting firm had not yet completed its year-end audit of the company's financial statements. Consulting firm Zolfo Cooper, LLC also has been retained to advise the firm on its profit and cost structure strategies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012365

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel